Answer
It is licensed for eligible children aged 6 years or older who weigh at least 15 kg and whose Gaucher disease type 1 is controlled on enzyme-replacement therapy.
Sources for this answer
- Cerdelga 84 mg capsules, hardemc · SmPC Current selected SmPC · Version 11